Intel has upsized its previously announced common-stock offering from $15 billion to $20 billion, pricing 210,526,315 shares at $95 apiece and expecting net proceeds of approximately $19.7 billion. The chipmaker disclosed the pricing on August 10, 2026, with closing set for August 12, and said the cash will be used for general corporate purposes including capital expenditures — code for its capital-hungry AI chip and foundry buildout.
An AI-era capital raise
J.P. Morgan, Goldman Sachs, Morgan Stanley and Citigroup are joint book-running managers of the offering, with a full syndicate that also includes Barclays, BofA, BNP Paribas, Credit Agricole CIB, Deutsche Bank, Mizuho, RBC, TD, Wells Fargo and Cantor. Underwriters received a 30-day option for up to 31.6 million additional shares, potentially pushing gross proceeds higher.
Why so much, why now
The upsize underscores just how expensive the semiconductor race has become. Intel is simultaneously trying to compete on AI accelerators, rebuild its contract-manufacturing (Intel Foundry) business, invest in advanced packaging and stand up new leading-edge process capacity such as Intel 14A. AI demand has raised the strategic value of domestic chip manufacturing, but fabs and new process nodes require enormous spending years before they generate meaningful returns. That leaves Intel walking a tightrope: dilution today in exchange for the balance sheet needed to remain competitive tomorrow.
The market context
Coming a day after NVIDIA teamed with Wall Street on a $500 billion compute-financing pact, Intel's raise fits a broader pattern of AI-era capital formation. Related coverage: Microsoft's Maia 300 chip plans and the Sony-TSMC $6.4B image-sensor JV.
Reporting based on coverage from Intel Newsroom, CNBC, Bloomberg and Quartz.